Biontech eps
WebMar 29, 2024 · Analysts estimate that BioNTech will report an earnings per share (EPS) of $8.19. BioNTech (NASDAQ:BNTX) is set to give its latest quarterly earnings report on Wednesday, 2024-03-30. WebSecond-Quarter 2024 Reported Diluted EPS(2) of $0.98, Adjusted Diluted EPS(3) of $1.07 ... the Pfizer-BioNTech SE (BioNTech) COVID-19 vaccine, as well as its business excluding BNT162b2(1). Additionally, Pfizer published this morning on its website the second-quarter 2024 earnings presentation and
Biontech eps
Did you know?
WebApr 6, 2024 · BioNTech SE (BNTX) latest earnings report: revenue, EPS, surprise, history, news and analysis. WebApr 13, 2024 · BIONTECH SE : Evolución y revisiones de las estimaciones de los analistas para las ganancias por acción y los ingresos de BIONTECH SE B1NT34 Bolsa de Valores de Sao Paulo ... Revisiones del consenso del EPS para el próximo año. Ajustes del presupuesto de ingresos. Ajustes del presupuesto del proximo año. CATEGORÍAS. …
WebOct 7, 2024 · BioNTech SE ADR analyst estimates, including BNTX earnings per share estimates and analyst recommendations. ... FY 2024 EPS Estimate Trends. Current: $33.49: 1 Month Ago: $34.41: 3 Months Ago: $35.47: Web1 day ago · BIONTECH SE company earnings calendar and analyst expectations - Upcoming and past events Bolsa de Valores de Sao Paulo: B1NT34 Bolsa de Valores de Sao Paulo ... EPS (Year) - Rate of surprise. Net sales (Quarter) - Rate of surprise EPS (Quarter) - Rate of surprise. CATEGORIES. Indexes; Equities; Currencies ...
WebApr 10, 2024 · Eps Diluted is a widely used stock evaluation measure. Find the latest Eps Diluted for BioNTech (BNTX) WebEPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that …
WebApr 11, 2024 · BioNTech SE (NASDAQ:BNTX) Analysts Just Slashed This Year's Estimates Mar 29 Full year 2024 earnings: EPS and revenues exceed analyst expectations Mar 29 These 4 Measures Indicate That BioNTech (NASDAQ:BNTX) Is Using Debt Safely Mar 05 A Look At The Fair Value Of BioNTech SE (NASDAQ:BNTX) Feb 18
WebBioNTech SE. Analyst Report: BioNTech SE BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as ... busch running for officeWebBioNTech SE (BNTX) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Add to watchlist 128.90 +3.30 (+2.63%) At close: 04:00PM EDT 129.10 +0.20 (+0.16%) After hours: 07:36PM EDT 1d 5d 1m 6m YTD... buscolindWebBioNTech SE (/ b iː ˈ ɒ n t ɛ k / bee-ON-tek; or / b aɪ ˈ ɒ n t ɛ k / bye-ON-tek short for Biopharmaceutical New Technologies) is a German biotechnology company based in … busco sxmWeb1 day ago · BIONTECH SE company earnings calendar and analyst expectations - Upcoming and past events Bolsa de Valores de Sao Paulo: B1NT34 Bolsa de Valores … busch light sweatshirt women\u0027sWebNov 8, 2024 · Registration requirements for medical devices in Vietnam are currently in a state of transition. New rules governing the registration of medical devices were … buses from cannock to penkridgeWebMar 27, 2024 · BioNTech press release (NASDAQ:BNTX): Q4 GAAP EPS of €9.26 beats by €1.51.; Revenue of €4.28B (-22.6% Y/Y) beats by €420M. Expanded and advanced … buschmann todWebThe average price target represents an increase of 52.89% from its latest reported closing price of $127.71. See our leaderboard of companies with the largest price target upside. The projected... buschwedding.minted.us